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ABSTRACT
Homologous recombination of single-stranded
oligonucleotides is a highly efficient process for
introducing precise mutations into the genome of
E. coli and other organisms when mismatch repair
(MMR) is disabled. This can result in the rapid accu-
mulation of off-target mutations that can mask de-
sired phenotypes, especially when selections need
to be employed following the generation of com-
binatorial libraries. While the use of inducible mu-
tator phenotypes or other MMR evasion tactics
have proven useful, reported methods either require
non-mobile genetic modifications or costly oligonu-
cleotides that also result in reduced efficiencies of re-
placement. Therefore a new system was developed,
Transient Mutator Multiplex Automated Genome En-
gineering (TM-MAGE), that solves problems encoun-
tered in other methods for oligonucleotide-mediated
recombination. TM-MAGE enables nearly equivalent
efficiencies of allelic replacement to the use of
strains with fully disabled MMR and with an approx-
imately 12- to 33-fold lower off-target mutation rate.
Furthermore, growth temperatures are not restricted
and a version of the plasmid can be readily removed
by sucrose counterselection. TM-MAGE was used
to combinatorially reconstruct mutations found in
evolved salt-tolerant strains, enabling the identifica-
tion of causative mutations and isolation of strains
with up to 75% increases in growth rate and greatly
reduced lag times in 0.6 M NaCl.
INTRODUCTION
The ability to rapidly and precisely manipulate the genome
of E.coliwas first revolutionized by the development of mo-
bile plasmids and prophages encoding inducible  Red re-
combinase (1,2). The success of these systems was due to
their mobility and curability as plasmids with temperature-
sensitive origins, the enhanced rates of recombination af-
forded by expressing a viral recombinase, and the natu-
ral propensity of the  subunit of  Red to inhibit E.
coli RecBCD exonuclease V. The latter feature allowed the
transformation of linear double-stranded DNA (dsDNA)
cassettes without degradation occurring too rapidly rela-
tive to recombination. It was additionally discovered that
single-stranded DNA (ssDNA) oligonucleotides could be
used to mediate homologous recombination without the
drawbacks of degradative activity against dsDNA, with
only the  subunit of  Red recombinase being required
for recombination (3). This discovery ultimately led to
the development of more specific techniques for ssDNA
oligonucleotide-mediated recombineering (4) andmultiplex
automated genome engineering (MAGE), where an electro-
poration mixture is cycled multiple times with multiplexed
pools of oligonucleotides synthesized individually or on ar-
rays to generate a combinatorial library of mutants (5,6).
Due to its ability to rapidly generate diversity at precisely
controlled locations, MAGE has opened up a diverse array
of applications in the fields of metabolic engineering, syn-
thetic biology and evolutionary biology. In metabolic engi-
neering, these include generation of precise mutant libraries
of interest, such as ribosome binding site libraries target-
ing one or more genes, promoter libraries and simultane-
ous manipulation of expression of genes in multiple path-
ways (5–7). In synthetic biology, applications have thus far
included genome-wide genetic reprogramming, such as re-
placement of all UAG stop codons with UAA (8) and rare
codon replacement in a panel of essential genes (9). In evo-
lutionary biology, MAGE has been used to combinatori-
ally reconstruct mutations identified in adaptive evolution
experiments to assess causality (10) and condition-specific
selection of antibiotic resistance (11).
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In spite of the wide range of opportunities presented by
MAGE, applications have lagged due to some limitations
of the MAGE systems published to date. Most notably, the
majority of previously reported systems achieved high ef-
ficiencies of replacement of single nucleotides through the
use of strains defective in mismatch repair (MMR) (by dele-
tion ofmutS, encoding one subunit of theMutHLSmethyl-
directed mismatch repair system) (4,5). Strains with dis-
abled MMR systems achieve multiple orders-of-magnitude
increases in efficiency for replacement of targeted single nu-
cleotides, however, they exhibit a mutator phenotype with
approximately 1000-fold increased spontaneous mutation
rates relative to strains with intactMMR (12,13). These off-
target mutations can potentially obfuscate results obtained
from libraries that undergo large numbers of MAGE cycles
or in MAGE applications where the generated combinato-
rial library is subsequently subjected to selections to iso-
late mutants with improved phenotypes. Resulting isolated
mutants also exhibit genomic instability unless MMR is re-
stored, thus deterring efforts to perform high-throughput
screening or subsequent strain manipulations. Additional
minor limitations include the use of relatively non-mobile
prophage-based systems, often with temperature-inducible
recombinases (4,5). These restrict the ability to easily re-
move the system following MAGE and limit growth both
during and after MAGE to temperatures of 32◦C or lower,
respectively.
The limitations in usingMMR defective strains have pre-
viously been addressed through the use of non-MMR de-
fective strains together with modifications that evade mis-
match repair. This includes strategies such as generating
mutations using particularmismatching base pairs (e.g. C:C
or A:G) (4), forcing the mutation of more than five bases
in a row (4), and the use of chemically modified bases that
can functionally replace standard bases while evading mis-
match repair (14). The former two strategies are undesir-
able as they significantly limit the scope of mutations possi-
ble to introduce byMAGE and preclude many applications
such as reconstructing combinations of specific mutations
observed in evolved strains and constructing fully diversi-
fied ribosome binding site libraries. The latter strategy in-
troduces very significant cost increases for oligonucleotides
and greatly reduced maximum measured allelic replace-
ment efficiencies of up to 5-fold were observed for modified
G (iso-deoxyguanosine) and A (2,6-diaminopurine) bases
(14).
An alternative strategy for overcoming the high off-target
mutation rate induced by permanent disabling of MMR
is the use of conditionally active mismatch repair proteins
(15). AMAGEhost strain was constructed byNyerges et al.
by introducing previously discovered mutations in MutS
andMutL that result in temperature-sensitive mismatch re-
pair activity (16) plus a prophage containing a temperature-
inducible  Red recombinase. This strain exhibited compa-
rable allelic replacement efficiencies to amutS− strain of up
to 25%, however, the spontaneous mutation rate remained
low only at temperatures below 32◦C. While a promising
strategy, the system would be difficult to employ in alterna-
tive host strains and would require either maintaining re-
sulting isolated mutants at or below 32◦C, or undergoing a
time-consuming process to remove the MAGE system and
revert the MMR proteins back to wild-type alleles.
In this study, we report a new plasmid-basedMAGE sys-
tem, TransientMutatorMultiplex Automated Genome En-
gineering (TM-MAGE) (Figure 1A), that overcomes the
limitations of previously reported methods that include
high off-target mutation rates, lack of mobility and cur-
ability of the system, and the lack of ability to cultivate
resulting mutant strains at 37◦C. This is accomplished by
transiently disabling MMR during MAGE cycling by in-
ducible overexpression of E. coli Dam methylase, together
with overexpression of the  subunit of Red in an artificial
operon on a plasmid. The dam gene target was identified
from an earlier screening study searching for native genes
that increased the spontaneousmutation rate inE. coliwhen
overexpressed (17). The efficiency and off-target mutation
rates were measured for this system and compared to the
EcNR2 strain (5), a plasmid-based system harboring only
 in a mutS+ host, and the same system in a mutS− host.
To further demonstrate the utility of this system, MAGE
was used to introduce several mutations that had previously
been identified in strains evolved for growth in high NaCl
concentrations (18). Subsequent selection was used to en-
rich the population in these mutants, and the off-target mu-
tation rate was shown to be substantially lower using TM-
MAGE than performing MAGE with a plasmid-based sys-
tem in a mutS− strain. A version of the plasmid containing
the sacB gene (encoding levansucrase from Bacillus subtilis)
enables one-step curing of the system by sucrose counterse-
lection.
MATERIALS AND METHODS
Chemicals, reagents and media
All chemicals and reagents were purchased from Sigma-
Aldrich (St. Louis, MO) unless otherwise stated. Tryptone
and yeast extract used for media preparation were pur-
chased from Sigma-Aldrich. LB medium (Lennox) used for
cultivations during MAGE cycling contained 10 g/l tryp-
tone, 5 g/l yeast extract and 5 g/l sodium chloride (Sigma).
An additional 0.5 mM MgSO4 was added to all LB me-
dia to correct an inherent magnesium limitation observed
with these media components. Strains harboring plasmids
were maintained with 100 g/ml ampicillin except dur-
ing growth for MAGE cycling and subsequent selections.
MacConkey agar was purchased from Becton Dickinson
(Franklin Lakes, NJ).
Oligonucleotides
All oligonucleotide sequences used in this study are shown
in Supplementary Table S1. MAGE oligonucleotides used
to introduce precise mutations that were previously iden-
tified for improved salt tolerance (18) (oligonucleotides 1
through 7) were designed using the MODEST oligonu-
cleotide design tool (19), with the length set to 70 bp, 15
bp minimum end homology and other options kept as de-
fault. Other MAGE control oligonucleotides (to introduce
premature stop codons in galK and xylA, oligonucleotides
8 and 9) were designed prior to the development of MOD-
EST and feature mutated bases centered in the middle of
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Figure 1. (A) Proposed mechanism of Transient Mutator Multiplex Automated Genome Engineering (TM-MAGE). Chromosomal mutations are intro-
duced via single-stranded oligonucleotide recombination on the lagging strand of replicating DNA, mediated by the  subunit of  Red recombinase.
Under ordinary conditions (left), the newly-synthesized strand is hemimethylated, which enables the MMR system, composed of MutS, MutL andMutH,
to bind to mismatched lesions and restore the wild-type allele. In standard MAGE (middle), the MMR system is eliminated, allowing incorporation of
the mismatched base and its complement base into the genome of one daughter cell after a second round of replication (red). However, permanent dis-
abling of mismatch repair also allows the accumulation of off-target mutations (yellow) during subsequent manipulations. In TM-MAGE (right), transient
overexpression of DNA adenine methylase (Dam) is hypothesized to generate significant methylation of the newly-synthesized strand, disabling detection
of incorporated mismatches by the MMR system and reducing the rate of off-target mutations that accumulate in subsequent manipulations as Dam
expression returns to its baseline level. (B) Schematic of TM-MAGE system plasmids pMA7 (top) and pMA7SacB (bottom). Plasmid pMA7 contains
an artificial operon of the gene encoding the  subunit of  Red recombinase and dam controlled by an arabinose-inducible (PBAD) promoter. Plasmid
pMA7SacB additionally contains constitutively expressed sacB (levansucrase from B. subtilis) to allow for plasmid curing by sucrose counterselection.
the oligonucleotide. For demonstration of the maximum
achievableMAGE efficiency for a single bp mismatch, a 90-
bp oligonucleotide that results in the same xylA premature
stop codon was designed with 4 phosphorothioated bases
introduced at the 5′ and 3′ termini (oligonucleotide 10).
All oligonucleotides were synthesized by Integrated DNA
Technologies (Leuven, Belgium) with standard desalting
and without additional purification.
Strains
Relevant strains used in this study are shown in Table 1.
K-12 MG1655 was kindly donated by Adam Feist (Uni-
versity of California, San Diego), which is equivalent to
ATCC 47076/CGSC 6300 (20). EcNR1 and EcNR2 are K-
12 MG1655 and K-12 MG1655 mutS::cat harboring a 
prophage at the attB site which contains a temperature in-
ducible  Red recombinase (5). K-12 MG1655 mutS::cat
was constructed by P1vir transduction of mutS::cat from
strain EcNR2 into donor strain K-12 MG1655. The mutS
replacement was confirmed by colony PCR using oligonu-
cleotides 11 and 12 as primers (Supplementary Table S1).
Plasmid construction
Plasmid pMA1 (GenBank accession number KT285943)
was constructed by PCR amplifying the gene encoding 
from strain EcNR1 (5), while also introducing a Shine–
Dalgarno sequence immediately upstream of the start
codon, using primers 13 and 14 and inserting the PCRprod-
uct between the NheI and HindIII sites in pBAD24 (21).
Plasmid pMA3 was constructed by amplifying dam from
K-12 MG1655, while also introducing a Shine–Dalgarno
sequence immediately upstream of the start codon, using
primers 15 and 16 and inserting between the NheI and
HindIII sites in pBAD18-Cm (21). Plasmid pMA7 (Gen-
Bank accession number KT285941) was constructed by
standard USER cloning (22) of three fragments, with the
first fragment amplified using primers 17 and 18 from tem-
plate pMA1, the second fragment amplified using primers
19 and 20 from template pMA1, and the third fragment am-
plified using primers 21 and 22 from template pMA3. Plas-
mid pMA7SacB (GenBank accession number KT285942)
was constructed using a Gibson Assembly Kit (New Eng-
land Biolabs). Primers 23 and 24 were used to PCR amplify
the parental pMA7 plasmid. The sacB gene was amplified
from E. coli DA16543 (donated by Dan Andersson, Upp-
sala University) using primers 25 and 26. Resulting DNA
fragments were assembled according to the manufacturer’s
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Table 1. Strains and plasmids used in this study
Strain/plasmid Relevant genotype/propertya Source/ Reference
Strains
K-12 MG1655 F−−ilvG- rfb-50 rph-1 A. Feist, UCSD
EcNR1 K-12 MG1655 -Red1 bla bio− CmR 5
EcNR2 K-12 MG1655 -Red1 bla bio− mutS− CmR 5
Plasmids
pMA1  subunit of  Red under PBAD promoter, AmpR, ColE1 origin from pBAD24 This study
pMA3 dam under PBAD promoter, CmR, ColE1 origin from pBAD18-Cm This study
pMA7  subunit of  Red and dam under PBAD promoter, AmpR, ColE1 origin from pBAD24 This study
pMA9  subunit of  Red and dam under PBAD promoter, AmpR, RSF1030 origin This study
pMA10  subunit of  Red and dam under PBAD promoter, AmpR, CloDF13 origin This study
pMA7SacB  subunit of  Red and dam under PBAD promoter, sacB from B. subtilis under constitutive
promoter, AmpR, ColE1 origin from pBAD24
This study
aAbbreviations: Amp, ampicillin; Cm, chloramphenicol; R, resistance.
instructions. All plasmids generated in this study are listed
in Table 1.
MAGE cycling
Starter cultures of K-12 MG1655 harboring plasmids
pMA7, pMA1 or pMA7SacB, or strain K-12 MG1655
mutS::cat harboring plasmid pMA1 were grown overnight
in LB + 100 g/ml ampicillin at 37◦C with 250 rpm shak-
ing. Strain EcNR2 was grown in LB overnight at 30◦C with
250 rpm shaking. After ∼16 h, 15 ml of LB medium (con-
taining 100 g/ml ampicilling where appropriate) in 50 ml
Falcon tubes was inoculated to an initial OD600 of 0.05, and
incubated at either 37◦C (K-12 MG1655 strains) or 30◦C
(EcNR2) until the OD600 reached 0.6–0.7. For strains har-
boring plasmids pMA7, pMA1 or pMA7SacB, the recom-
binase and dam functions were induced by addition of L-
arabinose to a final concentration of 0.2% w/v, and incu-
bation with shaking was continued for 10 min. For strain
EcNR2, the recombinase function was induced by transfer-
ring the culture to a 42◦C water bath with 200 rpm linear
shaking for 15 min. Cultures were then moved to an ice wa-
ter bath and chilled for 15 min. Cells were centrifuged in
Falcon tubes at 4000 x g for 5 min at 4◦C, the supernatant
was decanted and cells were subsequently resuspended in
30 ml, and thereafter 1 ml of autoclavedMilliQ water. Cells
were transferred to 2.0 ml microcentrifuge tubes and cen-
trifuged at 4000 x g for 5 min at 4◦C, the supernatant was
removed by pipetting, and cells were resuspended in 0.2
ml of autoclaved MilliQ water. Fifty microliters of cells
were then transferred to 1 mm gap electroporation cuvettes,
0.5 l of one oligonucleotide (for oligonucleotides 8, 9 or
10 resuspended to 100 nmol/ml in MilliQ water) or 3.5
l of a mixture of 7 oligonucleotides (for oligonucleotides
1 through 7, pre-mixed in a tube with a total concentra-
tion of 100 nmol/ml) was added, and mixed with a Pas-
teur pipette. Cells were immediately electroporated using
an ECM 399 electroporation system (Harvard Apparatus,
Holliston, MA) at 1.8 kV and 36 F (resulting in a 5 ms
pulse length) and resuspended in 950 l LB. The entire con-
tents of the electroporation cuvette were either transferred
into 50 ml Falcon tubes containing 14 ml of LB when more
cycles were to be performed in a single day (for 6 cycle ex-
periments, 3 cycles were performed per day), or into a 14 ml
culture tube containing 1 ml of LB when the final cycle of
the day was completed. Cultures were grown overnight at
37◦C (or 30◦C for strain EcNR2) with 250 rpm shaking to
allow for chromosome segregation.
For experiments performed during initial optimization
of dam expression, optimization of the pMA7 system, and
fluctuation tests for determination of mutation rates, an
identical procedure was performed except that 15 ml of LB
was inoculated 1:60 with starting culture, and centrifuga-
tion conditions were 6500 x g for 7 min at 4◦C for the first
two spins and 7000 x g for 30 s at 4◦C for the final spin in a
microcentrifuge. Induction of either arabinose-inducible or
temperature-inducible  or  Red was performed as previ-
ously described. For optimization of dam expression, cells
were either non-induced, induced before chilling and cen-
trifugation, induced immediately after electroporation, or
induced both before chilling and centrifugation and after
electroporation.
Plasmid curing
Following MAGE cycling and plating, individual colonies
were struck as wedges on plates containing 10 g/l tryptone,
5 g/l yeast extract, 15 g/l agar, and 5% w/v sucrose (added
from a 50% w/v stock after autoclaving the agar and media
components) and grown at 37◦C overnight. The next day,
individual colonies were restruck on LB agar and LB agar
containing 100 g/ml ampicillin to verify plasmid removal
by loss of ampicillin resistance.
Fluctuation tests
For the non-induced fluctuation tests, cultures were grown
to saturation overnight in LB, or when pMA7 or pMA1
plasmids were present, LB + 100 g/ml ampicillin. The fol-
lowing day, ten tubes containing 1.5 ml or 5 ml LB were
inoculated with 5 l of the saturated cultures. For non-
induced state fluctuation tests, cultures were grown again
to saturation overnight. For induced state fluctuation tests,
cultures were grown to OD600 0.4, induced with 0.2% L-
arabinose, and electrocompetent cells were prepared as de-
scribed above. Following electroporation with 5 pmol of
oligonucleotide 45, cells were grown to saturation in 5 ml
of LB overnight. The following day, 10 l (if a mutator
strain background) or 200 l (if a non-mutator strain back-
ground) was plated on LB agar containing 50 mg/ml ri-
fampicin, and 100 l (if a mutator strain background) or 1
ml (if a non-mutator strain background) was plated on LB
agar containing 50 mg/ml nalidixic acid. Cells were also se-
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rially diluted and plated on LB agar to determine total vi-
able cell counts. Mutation frequencies were determined as
the ratio of the number of colonies per ml culture appear-
ing on rifampicin or nalidixic acid plates to the total number
of viable colonies per ml culture.
Selections of combinatorial populations generated byMAGE
One milliliter of MAGE library cultures that were gener-
ated after 6 cycles using the 7 oligonucleotide mixture (1
through 7) were washed once to remove LBmedium by cen-
trifuging at 4000 x g for 1 min, removing the supernatant,
and resuspending in 1 ml of M9 medium. The resulting cell
suspensions were diluted 1:100 (25 l inoculum in 2.5 ml
medium) into either M9 medium or M9 containing an ad-
ditional 0.5 M NaCl in triplicates in 24 well plates. The M9
resuspended libraries were also serially diluted and plated
onM9 agar orM9 agar + 0.6MNaCl. After approximately
24 h, liquid cultures were passaged to an initial OD600 of
0.05 in fresh M9 medium, or in M9 medium containing 0.6
M NaCl, and this was repeated daily for 5 days (Supple-
mentary Figure S3). Each day, approximately 1.5–2.0× 109
cells were harvested from each culture by centrifugation at
16 000 x g for 2 min, and cell pellets were stored at −20◦C.
Following the fifth day, the cultures passaged in M9 + 0.6
MNaCl were serially diluted and spread on plates contain-
ing M9 agar + 0.6 M NaCl, to isolate individual colonies.
Individual colonies were selected and regrown on LB agar
for subsequent screening and analysis.
Determination of allele replacement efficiencies
Oligonucleotides 8, 9 and 10were designed to introduce pre-
mature stop codon mutations in xylA (encoding xylose iso-
merase) and galK (encoding galactokinase), thereby render-
ing cells incapable of catabolizing D-xylose or D-galactose.
To assess replacement efficiencies, cultures electroporated
with these control oligonucleotides were serially diluted in
phosphate buffered saline and plated on MacConkey agar
plates containing 1% w/v D-xylose (for oligonucleotides
8 and 10) or 1% w/v D-galactose (for oligonucleotide 9).
Plates were incubated overnight at 37◦C and colonies that
were either stained pink (wild-type) or white (mutant) were
counted.
Another measure of allele replacement efficiency, which
also enabled determination of replacement efficiencies using
the pooled NaCl oligonucleotides (1 through 7), was per-
formed using amplicon sequencing (23). Briefly, cell pellets
containing an estimated 5.0 × 108 to 1.5 × 109 cells (as-
suming OD600 1.0 = 1 × 109 cells/ml) were harvested by
centrifugation at 16 000 x g for 2 min, either during expo-
nential growth following an intermediate daily cycle, or fol-
lowing overnight outgrowth for the only or last daily cycle
performed. The supernatant was removed and cell pellets
were stored at −20◦C until further use. Selected amplicons
spanning a 150–170 bp region around targeted mutations
were amplified by colony PCR using primers containing 5′
overhangs complementary to priming sequences for Nex-
teraXT indexed adapters (SupplementaryTable S1, primers
27 through 44). Each PCR reaction contained 5 l of 2X
Phusion HotStart II master mix (Thermo Scientific), 0.25
l of forward primer (20 M), 0.25 l of reverse primer
(20 M), 3.5 l water and 1 l of resuspended cells (each
frozen cell pellet was resuspended in 300 l MilliQ water),
and was run in a thermal cycler with the following program:
(i) 98◦C for 3 min, (ii) 98◦C for 10 s, (iii) 56◦C for 30 s, (iv)
72◦C for 10 s, (v) Repeat steps 2–4 25 times, (vi) 72◦C for
5 min and (vii) hold at 4◦C. Different amplicons that could
be sequenced under the same index were pooled together
by combining 5 l of each PCR product and adjusting the
final volume to 50 l with water. The pooled PCR reac-
tions were cleaned up using Agencourt AmpPure XP beads
(BeckmanCoulter) per manufacturer directions, with the fi-
nal elution in 52.5 l of 10 mM Tris-HCl pH 8.5, of which
50 l was transferred to a new PCR plate. Pooled, cleaned-
up PCR products were amplified in a second PCR reaction
with Nextera XT index 1 and 2 primers supplied with the
Nextera XT 96 Index Kit (either 24 indices or 96 indices).
Each PCR reaction contained 12.5 l of 2X KAPA HiFi
HotStart ReadyMix (KAPA Biosystems), 2.5 l of a Nex-
tera XT index 1 primer, 2.5 l of a Nextera XT index 2
primer, 5 l of water and 2.5 l of pooled, cleaned-up PCR
product. The resulting products were cleaned-up again with
AmpPure XP beads and resuspended in 27.5 l of 10 mM
Tris-Cl pH 8.5, of which 25l was transferred to a newPCR
plate. Concentrations of each pooled indexed product was
determined using a Qubit dsDNA BR assay kit (Life Tech-
nologies, Carlsbad, CA), and PCR products were pooled to
a final total concentration of 10 nMofDNA in 10mMTris-
Cl pH 8.5 containing 0.1% v/v Tween 20. Manufacturer’s
instructions were followed for subsequent sequencing of li-
braries on a MiSeq sequencer (Illumina, San Diego, CA).
Analysis of amplicon sequencing data
A customMATLAB (MathWorks, Inc., Natick,MA) script
was used to count the frequencies of wild-type and mu-
tant alleles by searching fastq files for a 25-bp sequence
string flanking the mutation site (Supplementary Table S2),
and counting the numbers of wild-type and mutant se-
quences. The resulting counts were used directly to calcu-
late allelic replacement frequencies (ARFs) as (no. of mu-
tant sequences) / (no. of wild-type sequences + no. of mu-
tant sequences). Three biological replicates were analyzed
for allele frequencies during selections ofMAGE-generated
populations, and P-values were determined by a two-sided
t-test when averaged measurements were compared.
Growth screening
Biological triplicate colonies of selected isolates regrown
on LB agar were inoculated into 300 l M9 medium in
96-well deepwell plates and grown overnight at 37◦C with
300 rpm shaking. For primary screening, clear-bottomed
white 96-well half-deepwell plates (Enzyscreen B.V., Haar-
lem, Netherlands) containing 270 l of either M9 medium
or M9 medium + 0.667 M NaCl were inoculated with 30
l of the overnight cultures diluted 1:10 in M9 medium, to
bring to a final concentration of 0.6 M NaCl. Plates were
clamped down with sandwich covers (Enzyscreen) and in-
cubated at 37◦C with 225 rpm shaking in a Growth Pro-
filer (Enzyscreen), which optically scans the bottom of the
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plates. Scans were recorded every 15 min, and Growth Pro-
filer software was used to integrate green pixels in selected 1
mm diameter circular regions in each well. The green pixel
values were converted to approximate OD600 values using a
previously established calibration curve.
For secondary screening, 48-well FlowerPlates (m2plabs
GmbH, Baesweiler, Germany) were inoculated to an initial
OD600 of 0.03 (based on the pathlength for 200 l of di-
luted cultures in a 96-well plate, as measured on a Synergy
Mx plate reader (BioTek Instruments, Winooski, VT)) into
M9 medium or M9 containing an additional 0.6 M final
concentration of NaCl. The final volume in each well was
1.4 ml. Cultures were incubated in a BioLector microbiore-
actor system (m2p-labs) at 37◦C with 1000 rpm shaking,
with monitoring of the light backscatter intensity. Growth
curves were baseline-adjusted by subtracting out the mini-
mum light backscatter intensity in each well from all other
values in that well.
Whole genome resequencing of MAGE isolates
Single colonies from each isolate regrown on LB plates were
inoculated into LB medium and grown overnight at 37◦C
with 250 rpm shaking. Cell pellets were frozen at −20◦C
following centrifugation of 0.5 ml of culture at 16 000 x g
for 2 min and removal of the supernatant. Genomic DNA
was extracted from cell pellets using the PureLink Genomic
DNA Mini Kit (Life Technologies) following the manu-
facturer’s instructions, and was further concentrated and
purified by ethanol precipitation as previously described
(24). Genomic DNA concentrations used to calculate in-
put DNA for library preparation (200 ng in 55 l volume)
were quantified using a Qubit broad-range dsDNA assay
(Invitrogen). Libraries were prepared for sequencing using
the TruSeq Nano HT Library Preparation Kit (Illumina).
Sequence variants were determined from sequencing
fastq output files using breseq (25) version 0.24rc6 and
NCBIReference SequenceNC 000913.3 as the reference se-
quence, with a base quality cutoff of 20.All calledmutations
were present in >80% of the spanning reads and in regions
with coverage of more than 20-fold, with the exception of a
nagAA203Emutation which did not meet these criteria but
was detected in strain mutS pMA1 NaCl 20.
RESULTS
Feasibility of dam overexpression for MAGE
A requirement for high replacement efficiencies for the ma-
jority of single base pair mutations by  Red-mediated re-
combination of single-stranded oligonucleotides is inacti-
vation of the MMR system. This is typically achieved by
deletion of mutS or other genes in the MMR system, how-
ever, permanent inactivation can lead to a greatly elevated
spontaneous mutation rate both during and after MAGE.
Therefore, we reasoned that a gene that generates a muta-
tor phenotype when overexpressed would allow MAGE to
be performedwith transient inactivation ofMMR.The dam
gene was previously identified as the top hit in a screen for
genes that increase mutation rates when overexpressed (17).
Therefore dam was selected for assessment of whether over-
expression could enable high-efficiency allelic replacement
through  Red mediated recombination. A single cycle of
MAGE was performed using oligonucleotide 9 (to intro-
duce a premature stop codon in the galK gene) and strains
EcNR1 (mutS+) and EcNR2 (mutS−) harboring pMA3,
a medium-copy plasmid containing the dam gene under
control of an arabinose-inducible promoter. Four differ-
ent dam induction procedures were tested: non-induced, in-
duced immediately after electroporation, induced together
with the  Red genes before electrocompetent cell prepara-
tion, and induced both before electrocompetent cell prepa-
ration and after electroporation. Allelic replacement fre-
quencies (ARFs) were assessed by counting white (posi-
tive) and red colonies appearing on MacConkey agar con-
taining 1% galactose (Supplementary Figure S1). As ex-
pected, EcNR2 exhibited similar ARFs (6–10%) regardless
of dam induction. In strain EcNR1, an elevated ARF in
strain EcNR2was achieved upon induction of dam together
with  Red, thereby demonstrating the feasibility of dam
overexpression as an alternative to the use of permanent hy-
permutator strains(Figure 1A).
Development of a mobile MAGE system
In order to develop a mobile system that could be used for
growth at 37◦C, the  subunit of  Red recombinase was
cloned into pBAD24 (21) under control of an arabinose-
inducible promoter to generate plasmid pMA1 (GenBank
accession number KT285943). Next, dam was cloned in an
artificial operon downstream of  in pMA1 to generate
plasmid pMA7 (GenBank accession number KT285941)
(Figure 1B). Finally, as it would be desirable to remove any
plasmid-based MAGE system following its usage to gen-
erate mutations on the genome, the sacB gene was cloned
into pMA7 to generate plasmid pMA7SacB (GenBank ac-
cession number KT285942), thus enabling plasmid curing
by sucrose counterselection (Figure 1B).
Optimization of the pMA7 system for MAGE
To determine the optimal induction time for the artificial
operon containing dam and , single cycles of MAGE were
performed with control oligonucleotide 9 (which introduces
a premature stop codon in galK, preventing catabolism of
galactose) following induction of cultures with 0.2% w/v
L-arabinose for time periods between 5 and 30 min. The
frequency of replacement was assessed by plating cells on
MacConkey agar containing 1% galactose (Figure 2). A
maximum number of recombinants were obtained after 10
min induction time, therefore, this induction time was cho-
sen for subsequent recombineering experiments. In addi-
tion to the use of the pBAD24 backbone, systems were also
constructed by USER cloning to introduce origins of repli-
cation from pRSFDuet-1 and pCDFDuet-1 (Novagen) to
generate plasmids pMA9 and pMA10, respectively. These
systems were tested inK-12MG1655 using control oligonu-
cleotide 45 to introduce a premature stop codon in the
malK gene, rendering cells that receive the mutation un-
able to catabolize maltose. Based on counting red and white
colonies onMacConkey agar plates containing 1%maltose,
no statistically significant differences in the efficiency of re-
placementwere observed between these systems and pMA7.
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Figure 2. Allelic replacement efficiency (percent recombinants) with var-
ious lengths of Dam induction in K-12 MG1655/pMA7 prior to chilling
cells for electrocompetent cell preparation. Tenminutes was found to result
in optimal allelic replacement frequencies (ARFs) following a single cycle
of MAGE with an oligonucleotide introducing a premature stop codon in
galK (Y145*). ARFs were determined by counting red (wild-type allele)
and white (mutant allele) colonies appearing following plating on Mac-
Conkey agar containing 1% galactose.
Therefore the pMA7 system was selected for further char-
acterization.
Assessment of system performance
The replacement efficiencies obtained with K-12 MG1655
harboring the pMA7 and pMA7SacB systems (TM-
MAGE) were compared to strain EcNR2 using control
oligonucleotide 10 (which introduces a premature stop
codon in xylA, preventing catabolism of D-xylose). This
oligonucleotide had a length of 90 bp and incorporated
four phosphorothioated bases from the 5′ terminus, as this
length and 5′ phosphorothioation was determined to yield
optimal ARFs when introducing a nonsense mutation in
lacZ (5). Electroporated cells were outgrown overnight, and
ARFs were determined both by plating on MacConkey
agar containing 1% w/v D-xylose and by amplicon se-
quencing. The use of both pMA7 and pMA7SacB resulted
in approximately 20% ARF of xylA with the xylA Y13*
allele, as measured both by plate counts and amplicon se-
quencing (Figure 3). The use of EcNR2 resulted in a sim-
ilar 17% ARF as measured by plate counts, but interest-
ingly only a 3.5% ARF as measured by amplicon sequenc-
ing when searching for an exact sequence match to a 25 bp
region centered on the mutant or wild-type base. This per-
centage increased to only 5.8 ± 0.7% when first searching
for sequences containing the forward priming sequence for
xylA amplicon sequencing (43 in Supplementary Table S1)
and then searching only for sequences containing the mu-
tant or wild-type base and three preceding bases (TTCC
or TTCA, respectively). Qualitative inspection of all se-
quences containing the forward priming sequence indicated
an abundance of additional off-target mutations within the
region complementary to the oligonucleotide. These muta-
tions were likely responsible for alternative inactivations of
xylA and could thus account for numerous false positives
Figure 3. Transient expression of Dam enables efficient recombineering.
ARFs for xylA Y13* in strains EcNR2, K-12 MG1655/pMA7 and K-12
MG1655/pMA7SacB following one cycle of MAGE with a 90 bp phos-
phorothioated oligonucleotide. ARFs were determined both by counting
red (wild-type allele) and white (mutant allele) colonies appearing follow-
ing plating on MacConkey agar containing 1% xylose, and by amplicon
sequencing within the xylA locus. Error bars indicated standard deviations
about the mean of three replicates (two for K-12 MG1655/pMA7SacB).
on plates. Far fewer off-targetmutations were observedwith
the pMA7 and pMA7SacB systems, as evidenced by com-
parable ARFs determined by both plate counting and am-
plicon sequencing.
In a separate experiment, ARFs were compared over
6 MAGE cycles between K-12 MG1655/pMA7 (TM-
MAGE), K-12 MG1655/pMA1 and K-12 MG1655
mutS::cat/pMA1 separately using oligonucleotides 8 and
10 (which introduce premature stop codons in galK and
xylA, preventing catabolism of D-galactose and D-xylose,
respectively) (Figure 4). These oligonucleotides have
lengths of 70–72 bp and do not contain any phosphoroth-
ioated bases. Amplicon sequencing was performed using
cells collected during exponential growth following each
cycle or after overnight outgrowth (for the third and sixth
cycles). Increasing ARFs with a saturating trend were
observed using both control oligos, in general agreement
with predictions of replacement frequency as a function
of cycle number (5). The pMA7 system yielded similar
but slightly reduced ARFs for most cycles compared to
the hyper-mutator strain (mutS−) harboring the pMA1
system. The pMA1 system had a maximum ARF of only
0.3% after 6 cycles, as expected due to active mismatch
repair. Counting of white and red colonies on MacConkey
agar plates following the sixth cycle yielded nearly identical
ARF values to those measured by amplicon sequencing
and counting exact matches to a 25 bp region centered on
the wild-type or mutant base.
Curing of pMA7SacB
After 6 cycles of MAGE using either K-12
MG1655/pMA7SacB or pMA1, white colonies (xyl−)
growing on MacConkey agar plus 1% D-xylose were cured
as described in methods. Colonies were obtained overnight
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Figure 4. ARF from TM-MAGE with pMA7 are nearly equiva-
lent to those obtained when mismatch repair is permanently disabled.
ARFs for galK Y145* (top) and xylA Y13* (bottom) using 70-bp
non-modified oligonucleotides were determined by amplicon sequenc-
ing using cell pellets obtained following each of 6 cycles of MAGE in
strains K-12 MG1655/pMA1, K-12 MG1655/pMA7 and K-12 MG1655
mutS::cat/pMA1. ARFs were also determined from counting red (wild-
type allele) and white (mutant allele) colonies appearing following plating
after 6 cycles of MAGE on MacConkey agar containing galactose or xy-
lose. Measurements were performed on single replicates.
on sucrose and removal of pMA7SacB was verified by
lack of growth on LB plates containing ampicillin (Supple-
mentary Figure S2). Additionally, retainment of the xylA
Y13* allele following curing was qualitatively verified by
plating on MacConkey agar plus 1% D-xylose. Similar
results with overnight curing of the plasmid were obtained
with subsequent usage of pMA7SacB in our laboratory
for the introduction of other point mutations, with routine
removal of the plasmid by a single streaking and overnight
growth on sucrose-containing plates.
Determination of mutation frequencies resulting from dam
overexpression
While dam overexpression generates comparable ARFs as
when mutS− background hosts are employed, the primary
goal of finding an alternative inducible system that disables
mismatch repair is to reduce the background mutation rate
Figure 5. Spontaneous mutation rates are elevated only when Dam over-
expression is induced, and are reduced compared to permanently disabled
MMR. (A) Frequencies of rifampicin and nalidixic acid resistant mutants
following plating of non-induced strains (K-12 MG1655 with and with-
out pMA1, K-12 MG1655 mutS::cat with and without pMA1 and K-12
MG1655 with pMA7). (B) Frequencies of rifampicin and nalidixic acid
resistant mutants arising following plating of induced strains that had un-
dergone a procedure mimicking a single MAGE cycle. Individual replicate
measurements are shown, with the median value denoted by a horizontal
black line.
compared to that found in mutS− hosts. Therefore, fluctu-
ation tests were performed to measure the relative muta-
tion rates in K-12 MG1655 harboring pMA1, pMA7 and
K-12 MG1655 mutS::cat harboring pMA1, both with and
without induction of  and dam expression by addition
of L-arabinose. Strains without plasmids were also tested
as controls without induction. In non-induced tests, K-12
MG1655 harboring no vector, pMA1 and pMA7 exhibited
similar median resistant mutation frequencies of between
1.0 to 4.7 × 10−8 for rifampicin, and 1.3 to 3.5 × 10−9 for
nalidixic acid (Figure 5A). K-12 MG1655 mutS::cat har-
boring no vector and pMA1 exhibitedmutation frequencies
that were approximately 2 orders of magnitude higher for
rifampicin and between 2 to 3 orders of magnitude higher
for nalidixic acid. Thus, it is apparent that pMA7 does not
increase mutation rates without or prior to arabinose in-
duction, indicating effective repression of dam overexpres-
sion in the absence of inducing agent.With arabinose induc-
tion, median frequencies of resistant mutations for both ri-
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fampicin and nalidixic acid remained similar (within about
1 order of magnitude) to those without induction for K-
12 MG1655/pMA1 and K-12 MG1655 mutS::cat/pMA1,
while those for K-12MG1655/pMA7 increased by between
1 and 2 orders of magnitude, demonstrating an inducible
mutator phenotype while maintaining a 12- to 33-fold re-
duced rate of mutation following induction as compared
with a mutS− strain. This reduced mutation frequency is
likely at least in part due to the transient nature of dam over-
expression relative to the permanently disabled mismatch
repair present in mutS− strains.
System performance with subsequent selections
One of the primary applications ofMAGE is the generation
of combinatorial libraries of a set of mutant alleles. In order
to identify beneficial phenotypes from the resulting complex
pool, performing subsequent high-throughput screening or
selections is necessary. In the case when selections are per-
formed, it was anticipated that low ARFs (e.g. the pMA1
system in a mutS+ background) will lead to insufficient di-
versity in the starting pool of mutants and will hamper
efforts to isolate strains with highly improved phenotypes
derived from combinatorial mutations. It was also antici-
pated that in strains with permanently disabled MMR (e.g.
mutS−), accumulation of off-targetmutations during the se-
lection process would render phenotype to genotype rela-
tionships difficult to establish. TM-MAGE, which enables
both high efficiency allelic replacement to achieve both a
high diversity of combinatorial mutants and longer term
genomic stability following MAGE cycling, was expected
to lead to the isolation of strains with more improved phe-
notypes and with an improved ability to assign phenotype
to genotype.
This process was tested by constructing combinatorial
mutant libraries in strains K-12 MG1655/pMA7 (TM-
MAGE), K-12 MG1655/pMA1 (no mismatch repair) and
K-12 MG1655 mutS::cat/pMA1 (permanently disabled
mismatch repair). A pool of 7 oligonucleotides (1 through
7 in Supplementary Table S1) was transformed to intro-
duce mutations that were previously identified in strains
evolved for growth in high concentrations of NaCl (18).
These oligonucleotides were designed to either directly in-
troduce selected single nucleotide polymorphisms (SNPs)
from the G6 and A3 strains (18), or to introduce prema-
ture stop codons at the nearest possible location to where
insertion element sequences were located (as these muta-
tions represent probable losses-of-function). The pooled
oligonucleotides were transformed over 6 cycles of MAGE
and ARFs were determined using amplicon sequencing of
harvested cells after MAGE cycling. These frequencies are
shown as the initial data points in Figure 6 for each mu-
tant allele. Sixth cycle ARFs varied for different oligonu-
cleotides and for the different systems, with K-12 MG1655
mutS::cat/pMA1 generally exhibiting the highest ARFs,
TM-MAGE using K-12 MG1655/pMA7 exhibiting simi-
lar but slightly lower ARFs and K-12 MG1655/pMA1 ex-
hibiting greatly reduced ARFs. The mrdA Q51L (T:A) and
proVK12* (A:T) mutations, and to a lesser extent the nagA
A203E (G:T)mutation, appeared to largely evademismatch
repair in K-12 MG1655/pMA1 by unknown mechanisms.
Following 6MAGE cycles and overnight outgrowth, cells
were plated on M9 agar with or without 0.6 M NaCl, and
were also inoculated into liquid cultures of M9 medium
with or without 0.5 M NaCl (this concentration was in-
creased to 0.6 M NaCl with subsequent passages). Daily
passaging was performed with the liquid cultures (Supple-
mentary Figure S3), and after five passages and regrowth,
cells were plated on M9 agar containing 0.6 M NaCl to se-
lect individual isolates. Additionally, after days 1, 3 and 5 of
liquid culture passaging, cells were harvested for determina-
tion of the mutant allele frequency dynamics during selec-
tion using amplicon sequencing (Figure 6). Enrichment of
the frequency of a mutation as a function of selection time
in high NaCl concentrations is indicative of causality for
salt tolerance, whether alone or in combination with other
mutations. Only themrdAQ51L,msrBC118F, nagAA203E
and rpsA Q421K mutations were uniformly enriched dur-
ing passaging in M9 + 0.6 M NaCl following MAGE in
the mutS−/pMA1 and pMA7 harboring strains. With the
exception of the nagA A203E mutation in the population
generated with pMA7, these trends were specific to selec-
tions in high salt and mutations were not observed to be en-
riched by passaging inM9 only. The proVK12*mutant was
additionally enriched by passaging in high NaCl concen-
trations in mutS−/pMA1 (P = 0.002) but not significantly
for the pMA7-generated population. Following performing
MAGE in K-12 MG1655/pMA1, no enrichment pattern
could be discerned in high salt conditions, with the excep-
tion of nagA A203E. For many mutations, this was likely
due to their extremely low starting frequencies as a result of
activeMMRduringMAGE cycling. ThemrdAQ51Lmuta-
tion, which was present at a high starting frequency, exhib-
ited a lack of enrichment in high salt. Because this mutation
was enriched over 3–5 days using the otherMAGE systems,
a likely explanation is that this mutation is only beneficial
in combination with one or more other mutations.
In summary, enrichment of particular introduced muta-
tions following selection in high salt concentrations could
only be successfully observed when high ARFs could
be achieved by MAGE (i.e. with either K-12 MG1655
mutS−/pMA1 or K-12 MG1655/pMA7). This is most
likely due to the presence of strains in the starting popu-
lation that possess higher numbers of combinatorial muta-
tions (e.g. 3–5) that together impart tolerance to high salt
concentrations. From our amplicon sequencing data of the
selected populations, four causal mutations for NaCl toler-
ance out of the original seven introduced mutations could
be putatively identified using TM-MAGE: mrdA Q51L,
msrB C118F, nagA A203E and rpsA Q421K. The proV
K12* mutation was only observed to be enriched in the
mutS−/pMA1 background strain, thus it was not possible
to assign causality.
Screening and re-sequencing of selected isolates
For each of the three MAGE systems, a total of 20 isolates
from M9 + NaCl plates (10 each from plates spread with
cells immediately after MAGE cycling, and at the end of
serial passaging) were screened for growth in liquid culture
(M9 + 0.6 M NaCl) (Supplementary Figure S4). Primary
screening results were used to select two or three isolates
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Figure 6. Population frequencies of mutant alleles (indicated at right) as determined by amplicon sequencing following 6 cycles of MAGE and after 1,
3 and 5 days of daily passaging in M9 medium or M9 medium plus NaCl (0.5 M for the first passage and 0.6 M for subsequent passages). Libraries
were generated in K-12 MG1655/pMA7 (black bars), K-12 MG1655/pMA1 (gray bars) and K-12 MG1655 mutS::cat/pMA1 (white bars). Error bars
indicate standard deviations about the mean values of three biological replicate cultures. Only a single replicate was sequenced following 6 cycles ofMAGE,
therefore, no error bars are shown.
per system, which underwent secondary screening in a Bi-
olector microbioreactor system (Figure 7). Additionally for
each system, three isolates fromM9 plates that were spread
with cells immediately after MAGE cycling and one xyl−
isolate were screened under the same conditions.
A total of 20 isolates were whole-genome resequenced
with the goal of assessing typical numbers of off-target mu-
tations arising during multiple cycles of MAGE and sub-
sequent selections, as well as validating the causative mu-
tations inferred by amplicon sequencing (Table 2; full lists
of called sequence variants are provided in Supplementary
Data File 1). Although the mutation rate was shown to be
elevated over 10-fold in K-12 MG1655/pMA7 following a
typical single cycle ofMAGEand plating on highly selective
conditions compared to K-12 MG1655/pMA1, which har-
bors fully active mismatch repair (Figure 5), the duration
of this period of elevated mutation rate following induction
is not known largely due to the unknown turnover rate of
the overexpressed Dam protein. Additional cycling would
be expected to extend the duration of the elevated muta-
tion rate as a result of Dam overexpression, however, that
increase would only be expected to be linear with a high
Dam turnover rate. After 6 cycles of MAGE and plating
onMacConkey agar, xyl− isolates generated using both the
pMA7 and pMA1 system in the mutS− background strain
contained the target xylA Y13* mutation. The isolate gen-
erated by the pMA1 system contained two off-target muta-
tions immediately adjacent to the target site (a 4-bp dele-
tion beginning at the same genome coordinate as the Y13*
mutation and a G→T mutation 5 bases away from that co-
ordinate) that would also be expected to result in a loss-of-
function of xylA. Aside from the off-targetmutation in xylA
using the pMA1 system, there was a single off-target muta-
tion using pMA7, none using pMA1 and 16 using pMA1 in
the mutS− strain (excluding mutations that were common
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Figure 7. Strains with the highest growth rates and greatly reduced lag times were reliably isolated fromNaCl-selected libraries generated using TM-MAGE,
as compared to other MAGE systems. (A–C) Averaged growth curves across three biological replicate cultures of control strains and individual isolates
(A: K-12 MG1655/pMA7, B: K-12 MG1655/pMA1, C: K-12 MG1655 mutS::cat/pMA1) following 5 days of passaging on M9 + NaCl. (D) Calculated
growth rates and (E) lag times of starting strains and isolated strains following M9 + NaCl selections. Error bars represent standard deviations about the
mean of three biological replicate measurements.
across all sequenced mutS− strains that can be assumed to
be present in the original background strain).
Following selection on M9 plates or after liquid passag-
ing in M9 + NaCl (Table 2), K-12 MG1655/pMA7 iso-
lates harbored between 1 and 5 off-target mutations (in iso-
late pMA7-NaCl-15 with 5 off-target mutations, one was
within the sequence of oligonucleotide 7). By contrast, K-12
MG1655/pMA1 isolates harbored between 0 to 1 off-target
mutations and strains using pMA1 in the mutS− back-
ground harbored 7–25 mutations (7–14 from selection in
M9, and 9–25 from selection inM9+NaCl). Thus, while the
mutation rate using the pMA7 system is generally elevated
compared to pMA1 in amutS+ background, there are fewer
off-target mutations than in a mutS− background, and off-
target mutations were not particularly more abundant fol-
lowing selection in the condition with a higher selective
pressure (liquid passages followed by plating on M9 agar +
NaCl) versus the condition with the lower selective pressure
(plating onM9 agar). This is suggestive that most off-target
mutations arose duringMAGE cyclingwhenDamwas peri-
odically induced, rather than during subsequent selections.
Further investigating on-target mutations in the NaCl-
selected mutants, strains isolated from the pMA7 pop-
ulation harbored between 3 and 5 on-target mutations,
while those from the pMA1 population harbored 2 and
those from the mutS−/pMA1 population harbored 3 on-
target mutations (Table 3). The strains isolated from the
pMA1 population both contained the mrdA Q51L and
nagAA203E mutations, which along with proVK12*, were
the only mutations with elevated ARFs using this system,
likely due to full or partial evasion of the mismatch re-
pair system. Thesemutants exhibited only slightly improved
growth in M9 + 0.6 M NaCl compared to the wild-type
strain (Figure 7). By contrast, two out of three strains iso-
lated from the pMA7population contained themrdAQ51L,
nagA A203E, rpsA Q421K and msrB C118F mutations.
The presence of these mutations is consistent with enrich-
ments observed during passaging in M9 + NaCl by am-
plicon sequencing (Figure 6). Strains pMA7 NaCl 12 and
pMA7 NaCl 15 exhibited a much greater improvement in
growth inM9+ 0.6MNaCl compared to the pMA1 isolates
(Figure 7), with growth rates of 0.35± 0.03 and 0.30± 0.02
h−1, respectively, compared to the K-12 MG1655 growth
rate of 0.20± 0.01 h−1. Lag times were also reduced in these
isolates to 5.2 ± 0.5 and 3.6 ± 0.5 h, respectively, compared
to 8.9 ± 1.0 h for K-12 MG1655. These strains in partic-
ular share the combination of all four of the above men-
tioned mutations. Strains isolated from the mutS− popula-
tion harbored 3 mutations (all three contained mrdA Q51L
and rpsA Q421K, with different third on-target mutations
in each isolate) and also significantly improved growth phe-
notypes compared toK-12MG1655mutS::cat (0.22 to 0.23
h−1 compared with 0.15 h−1). However, the presence of a
large number of off-target mutations rendered it difficult to
assign causation of the phenotype to the sets of on-target
mutations that were identified.
DISCUSSION
The ability to use short (<100-bp), chemically synthesized,
single-stranded oligonucleotides to precisely modify and
edit genomes has opened up possibilities in a wide array
of applications. To date, these have included the generation
of combinatorial libraries targeting ribosome binding sites
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Table 2. On-target and off-target mutations in re-sequenced isolates (20 total) following 6 cycles ofMAGE to introduce the xylAY13*mutation, in isolates
following plating on M9 agar after MAGE cycling with a pool of 7 oligonucleotides designed to introduce mutations observed in evolved NaCl-tolerant
strains, and in isolates cycled with the same oligonucleotide pool after 5 days of serially passaging cultures in M9 + NaCl and plating on M9 agar + NaCl
6th cycle xylA* M9 M9 + NaCl
on-target off-target on-target off-targeta on-target off-targeta
pMA7 rep. 1 1 1 1 1 3 1
pMA7 rep. 2 - - 3 4 4 4 + 1b
pMA7 rep. 3 - - 0 2 5 4
pMA1 rep. 1 0 2b 1 0 - -
pMA1 rep. 2 - - 1 0 2 1
pMA1 rep. 3 - - 0 0 2 1
mutS−/pMA1 rep. 1 1 16 4 14 3 25c
mutS−/pMA1 rep. 2 - - 0 7 3 9
mutS−/pMA1 rep. 3 - - 2 10 3 15
aNot including pre-existing mutations occurring across all mutS- strains.
bOff-target mutations were within the oligonucleotide sequence.
cNot including a number of called missing coverage deletions (total of 43).
Table 3. On-target mutations identified in isolates following plating on M9 agar after MAGE cycling, and in isolates after 5 days of serially passaging
cultures in M9 + NaCl and plating on M9 agar + NaCl
MAGE system Isolate name M9 on-target mutations Isolate name M9 + NaCl on-target mutations
K-12 MG1655/
pMA7
pMA7 M9 1
pMA7 M9 2
pMA7 M9 3
mrdA Q51L
nagA A203E, ydjK P17S, proV K12*
none
pMA7 NaCl 11
pMA7 NaCl 12
pMA7 NaCl 15
nagA A203E, rpsA Q421K, msrB C118F
mrdA Q51L, nagA A203E, rpsA Q421K, msrB C118F
mrdA Q51L, nagA A203E, rpsA Q421K, msrB C118F,
ydjK P17S
K-12 MG1655/
pMA1
pMA1 M9 1
pMA1 M9 2
pMA1 M9 3
mrdA Q51L
proV K12*
none
pMA1 NaCl 11
pMA1 NaCl 15
pMA1 NaCl 19
-
mrdA Q51L, nagA A203E
mrdA Q51L, nagA A203E
K-12 MG1655
mutS::cat/
pMA1
mutS pMA1 M9 1
mutS pMA1 M9 2
mutS pMA1 M9 3
nagA A203E, ydjK P17S, msrB C118F, proV K12*
none
msrB C118F, proV K12*
mutS pMA1 NaCl 15
mutS pMA1 NaCl 17
mutS pMA1 NaCl 20
mrdA Q51L, rpsA Q421K, ydjK P17S
mrdA Q51L, nagA A203E, rpsA Q421K
mrdA Q51L, rpsA Q421K, msrB C118F
(RBS) of genes involved in biochemical production path-
ways (5), redesign of the entire genome via genome-wide
stop codon replacement and replacement of rare codons
(9), genome-wide promoter replacement (6), and combina-
torial library generation followed by selection to identify
causative combinations of mutations found in adaptively
evolved strains (10). In all published applications besides
the last example, which had utilized the pMA7 system in
advance of this publication, strains deficient in mismatch
repair (mutS−) have been employed and the impact of off-
target mutations on the phenotype of the final selected or
screened strains has largely not been reported. An average
of 113 off-target mutations were identified in strains with
UAG stop codons converted to UAA (26), and 355 off-
target mutations were reported in a strain with all UAG
stop codons converted to UAA (8). These off-target muta-
tions are likely to affect strain phenotype, particularly when
strains are subjected to selective pressures to identify iso-
lates with improved phenotypes. As an example of this, we
have generated MAGE libraries containing random RBS
insertions upstream of 70 transcription factors in a mutS−
host and have conducted short-term selections (3 passages)
in stress conditions to identify stress-tolerant mutants. Re-
sequenced isolates from these selections exhibited greatly
improved tolerance, however, only 4 out of 11 strains con-
tained targeted RBS modifications, and of those that did, it
was not possible to reconstitute tolerance by re-introducing
only the identified RBS modifications into the background
strains (Supplementary Figure S5).
In this study, a new plasmid-based system for performing
MAGE, TM-MAGE, is reported that transiently inhibits
methyl-directed mismatch repair through inducible overex-
pression of the Dam methylase while simultaneously ex-
pressing the  subunit of  Red recombinase. Dam over-
expression has long been known to result in an increased
mutation rate due to increased methylation of both the tem-
plate strand and newly synthesized strand during replica-
tion, due to hemimethylation being required for recognition
of the newly synthesized strand by the MMR system (28).
The systemwas shown to have a nearly equivalent frequency
of allelic replacement as mutS− strains (either EcNR2 or
K-12 MG1655 mutS::cat). Furthermore, while inducing a
mutator phenotype, a much lower occurrence of off-target
mutations was observed compared with permanent inacti-
vation of MMR, with an over 5-fold reduction in the aver-
age number of off-target mutations in re-sequenced isolates
following 6 cycles of MAGE and 5 days of selections under
osmotic stress conditions compared tomutS− mutants. This
is likely a result of transcription of plasmid-based dam only
being induced during MAGE cycling, with natural pro-
tein turnover restoring ordinary DNA hemimethylation in
subsequent generations. Nyerges et al. have also addressed
the issue of off-target mutations in MMR-deficient hosts
during MAGE through the introduction of temperature-
sensitive MutS and MutL protein alleles into a host strain,
resulting in an over 6-fold reduction in off-target mutations
following 20 cycles of MAGE (15). However, utilization of
this system necessitates that the MAGE background strain
first possess the two temperature-sensitive alleles in addition
to a system for expressing Red recombinase (in this case a
prophage-based recombinase was employed). Accordingly,
mutants constructed using this system must be cultivated
at temperatures less than 32◦C to ensure active mismatch
repair unless the non-temperature-sensitive alleles are re-
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stored. TM-MAGE addresses these limitations, as neces-
sary functions are self-contained on a plasmid that can eas-
ily be transformed into any host strain, and can either be left
in the host strain without cultivation temperature restric-
tions, or easily removed in a single day by sucrose counter-
selection when pMA7SacB is employed. These features en-
able robust generation of combinatorial libraries and pre-
cisely edited genomes with the ability to much more defini-
tively assign phenotype to genotype due to the significantly
reduced rate of accumulation of off-target mutations.
In the previous publication in which TM-MAGE
(pMA7) was utilized (10), a detailed analysis of system per-
formance with respect to ARFs and off-target mutation
rates had not been performed. A total of nine cycles of
MAGE were performed over three days (in comparison to
the 6 cycles in 2 days performed in this study, thus length-
ening the total time in which Dam was overexpressed),
followed by serial passaging under the selection condition
(42◦C) during continuous exponential growth for 3 days.
In 43 resequenced isolates (10), a median of 4 off-target
mutations and 3 on-target mutations were observed. Af-
ter removing off-target mutations that occurred within the
oligonucleotide sequences, mutations that occurred spon-
taneously in the pyrE/rph intergenic region or rph gene,
and larger detected areas of missing coverage in a few
strains, the median number of off-target mutations dropped
to two. These mutations were not considered due to possi-
ble oligonucleotide synthesis errors, mutations in pyrE/rph
correcting a known defect in K-12 MG1655 growth in min-
imal medium (27) and appearing to be especially selected
for at 42◦C, and the likely presence of sequencing arti-
facts in the strains with many called missing coverage dele-
tions (and if present, would unlikely be a result of disabled
MMR), respectively. These results are comparable with the
off-target mutation rates observed in this study and offer
further support of the greatly reduced background muta-
tion rate achievable by TM-MAGE relative to strains with
permanently disabled MMR.
It should be noted that a potential limitation of TM-
MAGE is the continued accumulation of off-target muta-
tions during MAGE cycling. Similar numbers of off-target
mutations were observed in re-sequenced isolates that had
undergone 6 (this study) or 9 cycles of TM-MAGE (10). By
constrast, a single cycle ofMAGEwas shown to generate an
approximately one order-of-magnitude increase in the fre-
quency of mutations providing resistance toward nalidixic
acid or rifampicin (Figure 5B). This is suggestive of a non-
linear accumulation of off-target mutations as a function
of MAGE cycle number, and is likely a result of elevated
Dam protein levels persisting during and after cycling in at
least a portion of the passaged population in subsequent
cycles. Despite that significant increases in off-target mu-
tations were not observed after 9 cycles, it is recommended
that TM-MAGE cycles be limited in number in applications
where off-target mutations would be particularly problem-
atic. Experiments should be appropriately scaled with re-
gards to both the pooled oligonucleotide diversity and the
ability to screen or select desired phenotypes from the re-
sulting populations. In the case of performing selections fol-
lowing any MAGE protocol, consideration must be given
to the ability to enrich a particular mutant in a timeframe
shorter than that required for cells to undergo adaptive lab-
oratory evolution. Despite these potential limitations, the
off-target mutation rate using TM-MAGE is significantly
lower than when performingMAGE in strains with perma-
nently disabled MMR and is thus better suited for experi-
ments requiring larger numbers of cycles.
We demonstrated the power of using TM-MAGE to re-
construct causative mutations for tolerance to growth in
highNaCl concentrations. Thesemutations were previously
identified in the two best-performing isolates from adaptive
laboratory evolutions of F− and F+ Hfr strains on high con-
centrations of NaCl (18). In that study, causative mutations
were only partially explored through reconstruction of com-
binations of loss-of-function mutations, and through over-
expression of the different mutated gene targets which only
identified ydjK as improving osmotolerance. We here show
that an improved combination of mutations with a relative
fitness (growth rate of mutant / growth rate of wild-type
− 1) in M9 + 0.6 M NaCl of 0.75 could be achieved us-
ing TM-MAGE, compared to reported fitnesses of 0.5 for
the original evolved strains in M9 + 0.65 M NaCl and less
than 0.5 for all overexpression and knockout mutants in
M9 + 0.55 M NaCl (18). These TM-MAGE constructed
strains harbored a combination of four mutations originat-
ing from both of the original evolved strains: mrdA Q51L,
nagA A203E, rpsA Q421K and msrB C118F. Due to their
extremely low initial frequency in the population, it was not
possible to adequately select for mutants with this degree of
improvement in growth phenotype from populations gener-
ated using pMA1 (which harbored an intactMMR system).
And due to the high rate of off-target mutations likely oc-
curring both before, during, and after MAGE in a strain
with permanently disabled mismatch repair, it was also
not possible to isolate mutants with significantly improved
growth rates over wild-type K-12 MG1655, nor to assign
causation from patterns in the growth behaviors of indi-
vidual isolates. However, performing TM-MAGE with the
pMA7 system, we were able to rapidly isolate improved os-
motolerant mutants with combinations of mutations origi-
nally found in distinct evolved isolates.
TM-MAGE should find broad applicability as a replace-
ment for other MAGE systems. New features that have pre-
viously hindered the use of MAGE include the ability to
efficiently generate mutations and libraries of mutations in
alternative host strains, and the rapid removal of the system
for use of MAGE in metabolically engineered production
hosts or any other application where a clean strain back-
ground is desired. Most importantly, we have demonstrated
the ability to couple TM-MAGE robustly with subsequent
selections, which will enable the full exploration of the gen-
erated mutational space for desired selectable phenotypes.
This is particularly useful for reconstructing and identify-
ing causal mutations in strains isolated by adaptive labora-
tory evolution. Use of TM-MAGEwill also lead to the gen-
eration of more stable genotypes for subsequent screening
applications, when compared to systems with permanently
disabled MMR.
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ACCESSION NUMBERS
Sequences for plasmids pMA1, pMA7, and pMA7SacB
have been deposited as Genbank accession numbers
KT285943, KT285941 and KT285942, respectively.
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Supplementary Data are available at NAR Online.
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